Navigation Links
Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
Date:3/26/2008

ults for the fourth quarters of 2007 and 2006 include non-cash charges relating to stock-based compensation of $79,260 and $150,796, respectively.

As a development stage pharmaceutical company, Catalyst had no revenues during 2007 and 2006.

At December 31, 2007, the Company had cash and cash equivalents totaling $15.9 million and no long-term debt. The Company believes that its existing cash and cash equivalents will be sufficient to meet its projected operating requirements through the middle of 2009.

Company Development Update

In August 2007, Catalyst submitted to the U.S. Food & Drug Administration (FDA) the results of a bioequivalence study demonstrating that CPP-109 is bioavailable and bioequivalent to Sabril(R) Tablets, the version of vigabatrin marketed in Europe by Sanofi Aventis.

In December 2007, Catalyst announced positive initial top-line results from a Catalyst-supported, investigator-initiated, Phase II double-blind, placebo-controlled trial, in which vigabatrin met its primary efficacy endpoint of abstinence during the last weeks of treatment for cocaine addiction. Additional results of this trial will be reported when they become available. This 103-subject trial is the first randomized, double-blind, placebo-controlled clinical trial studying vigabatrin's effectiveness in treating cocaine addiction. These data show that a statistically significantly greater number of subjects treated with vigabatrin were able to abstain from cocaine usage during the last three weeks of the dosing period compared to those receiving placebo. Achievement of abstinence for an extended period during treatment is the critical first step for cocaine addicted patients to potentially achieve abstinence for much longer time periods. The data confirm the positive results seen in two previous open-label trials conducted in 2003 and 2004.

In January 2008, Catalyst announced that it has initiated enrollment of patients for its 180-patient
'/>"/>

SOURCE Catalyst Pharmaceutical Partners
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... LA HABRA, Calif. , May 1, 2015 /PRNewswire-USNewswire/ ... to announce its 2015 health literacy award winners. The ... reward initiatives that make an impact on the practice ... that advance health literacy. IHA gives awards in three ... IHA also bestowed its Health Literacy Hero award. ...
(Date:5/1/2015)... 1, 2015 Semler Scientific, Inc. (Nasdaq: ... develops, manufactures and markets products that assist healthcare providers ... financial results for the first quarter ended March 31, ... 2015, Semler reported continued progress with year over year ... growth of 14%," said Doug Murphy-Chutorian , M.D., ...
(Date:5/1/2015)... NEW YORK , May 1, 2015  Shares ... over 70% of their value yesterday following the results ... company,s glaucoma therapy, Rhopressa.  Despite the trial failing to ... indicates that positive results may come from future studies. ... a brief company overview, current pipeline, financial review, analyst ...
Breaking Medicine Technology:Institute for Healthcare Advancement Announces 2015 Award Winners 2Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... 12, 2011 Reportlinker.com announces that a new ... Global Injectable Drug Delivery Market ... Report Description : ... * To define and measure the Injectable drug ...
... BOSTON, Oct. 12, 2011 PAREXEL International Corporation ... biopharmaceutical services provider, today announced that it has ... topics throughout the clinical development and commercialization lifecycle. ... are conversations with thought leaders from PAREXEL designed ...
Cached Medicine Technology:Global Injectable Drug Delivery Market (2010 - 2015) 2Global Injectable Drug Delivery Market (2010 - 2015) 3Global Injectable Drug Delivery Market (2010 - 2015) 4Global Injectable Drug Delivery Market (2010 - 2015) 5Global Injectable Drug Delivery Market (2010 - 2015) 6Global Injectable Drug Delivery Market (2010 - 2015) 7Global Injectable Drug Delivery Market (2010 - 2015) 8Global Injectable Drug Delivery Market (2010 - 2015) 9Global Injectable Drug Delivery Market (2010 - 2015) 10Global Injectable Drug Delivery Market (2010 - 2015) 11Global Injectable Drug Delivery Market (2010 - 2015) 12New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership 2New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership 3New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership 4
(Date:5/3/2015)... 03, 2015 Looking for a ... directly impact your career? The Master of International ... leaders in multinational companies and for professionals seeking ... changing global landscape, differences in culture, religion, government, ... EMIB program develops the global competence and confidence ...
(Date:5/3/2015)... 2015 SpineFrontier, a Less Exposure Surgery ... to produce and market their new sacroiliac joint fusion ... in outpatient settings and is compatible with both lateral ... has been extensively researched and refined by SpineFrontier, the ... this approach in conjunction with a sacroiliac joint fusion ...
(Date:5/3/2015)... 2015 HealthPostures, a pioneering ergonomics ... its appearance at the , May 5 - 7, ... will exhibit at the conference include its bestselling TaskMate ... solutions is the 6100 TaskMate Executive. Features of the ... adjustable keyboard tray, extended platform work surface and supply ...
(Date:5/2/2015)... NV (PRWEB) May 02, 2015 Ticket Down ... tickets for the long awaited event today, Saturday, May ... Diehard boxing fans will be able to secure tickets ... , The fight that boxing fans have wanted for more ... months ago. Floyd “Money” Mayweather will step inside the ring ...
(Date:5/2/2015)... ActOn ” was featured on NewsWatch as part of its ... coolest applications on the market for iOS, Android, and Windows. ... the app review and shared with viewers how this app ... difference. , In this material world, almost everything is about ... which is why those things should be prioritized above others. ...
Breaking Medicine News(10 mins):Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2
... who were treated with anti-tumor necrosis factor alpha, ... exacerbations than individuals taking a placebo. ,This ... 2006 of the American Journal of Respiratory and ... Society. ,Trevor T. Hansel, M.D., Ph.D., ...
... care in United Kingdom, and a munificent grant of ?45 ... figure anywhere on the NHS dental list. , ,The ... NHS registrations, down by a 42000 enrollments. This, notwithstanding the ... to ensure registrations are maintained. Yet, it has not made ...
... professor says that laws, which require minors to seek ... sexual behavior// in this segment of the society. Jonathan ... Thomas Stratmann, professor of economics at George Mason University ... laws seeking parental consent may play an important role. ...
... developed a prototype bandage that could detect hidden fractures once ... by Ozan Akkus and colleagues at Purdue University in Indiana ... created by tiny cracks in damaged bones, reported the online ... alarm, warning the patient to rest so that the injured ...
... capital has recorded 327 cases of dengue fever this year so ... ,According to health authorities here, two more people have died ... nine. ,Out of the 327 cases reported, 127 cases ... that the next two months is likely to see a surge ...
... The directory of patented drugs will play host to a ... to the recent communique // by the Director of patent ... in the arm for the multitude of generic drug manufacturers, ... the drug to developing nations. ,Biolyse ...
Cached Medicine News:Health News:Monoclonal Antibody Reduces Exacerbations in Asthmatics 2Health News:Laws That Make Parental Consent Mandatory Reduce Risky Sexual Behavior 2
8 mm S Graftech cervical spacer....
... system for procedures in the ... system features a broad selection ... for many Craniomaxillofacial procedures. 1.5 ... used predominately in the less ...
A unique system for secure fixation of the cranial bone flap after craniotomy. Craniofix eliminates the need for mini plates, screws, and additional drills....
... Timesh 1.5 Titanium Cranial Fixation Systems ... benefits specifically requested by surgeons and ... cranioplasty implants may be either shaped ... procedure warrants, a pre-measured, cut, bent ...
Medicine Products: